The Insights Report – Education

We are pleased that Skip Capital and Stonepeak Partners recognise the value in Genex.

Botanix Pharmaceuticals has announced its BTX 1702 Phase 1b/2 clinical study on papulopustular rosacea has produced clinically meaningful data.